Elevation Oncology Stock Net Asset
| ELEVDelisted Stock | USD 0.37 0.00 0.00% |
Fundamental analysis of Elevation Oncology allows traders to better anticipate movements in Elevation Oncology's stock price by examining its financial health and performance throughout various phases of its business cycle.
Elevation |
Elevation Oncology Company Net Asset Analysis
Elevation Oncology's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Elevation Oncology Net Asset | 95.63 M |
Most of Elevation Oncology's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elevation Oncology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
CompetitionBased on the recorded statements, Elevation Oncology has a Net Asset of 95.63 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Elevation Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Elevation Oncology's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Elevation Oncology could also be used in its relative valuation, which is a method of valuing Elevation Oncology by comparing valuation metrics of similar companies.Elevation Oncology is currently under evaluation in net asset category among its peers.
Elevation Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | (27.78 M) | |||
| Shares Outstanding | 59.25 M | |||
| Shares Owned By Insiders | 0.35 % | |||
| Shares Owned By Institutions | 59.72 % | |||
| Number Of Shares Shorted | 2.08 M | |||
| Price To Earning | 0.16 X | |||
| Price To Book | 0.46 X | |||
| EBITDA | (44.7 M) | |||
| Net Income | (44.48 M) | |||
| Cash And Equivalents | 122.54 M | |||
| Cash Per Share | 5.26 X | |||
| Total Debt | 31.13 M | |||
| Current Ratio | 6.48 X | |||
| Book Value Per Share | 0.79 X | |||
| Cash Flow From Operations | (36.36 M) | |||
| Short Ratio | 0.91 X | |||
| Earnings Per Share | (0.81) X | |||
| Target Price | 0.4 | |||
| Number Of Employees | 34 | |||
| Beta | 1.5 | |||
| Market Capitalization | 21.63 M | |||
| Total Asset | 95.63 M | |||
| Retained Earnings | (240.46 M) | |||
| Working Capital | 90.26 M | |||
| Net Asset | 95.63 M |
About Elevation Oncology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elevation Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elevation Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elevation Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in commodities. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Elevation Stock
If you are still planning to invest in Elevation Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elevation Oncology's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |